Pilot scale culture of the marine cyanobacterium Lyngbya majuscula for its pharmaceutically-useful natural metabolite curacin A

Journal of Applied Phycology

Volumn 9, Issue 3, 1997, Pages 195-204

  Rossi, James V ^a   Roberts, Mary Ann ^a   Yoo, Hye Dong ^a   Gerwick, William H ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Biotechnology; Curacin A; Cyanobacteria; Lyngbya majuscula

Indexed keywords

BIOTECHNOLOGY; CULTURE; CURACIN A; CYANOBACTERIA; METABOLITE; METABOLITES; PILOT-SCALE CULTURE;

CURACAO;

LYNGBYA MAJUSCULA;

EID: 0030665849     PISSN: 09218971     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007973009869     Document Type: Article

References (20)

1. Armstrong JF, Janda KE, Alvarado B, Wright AE (1991) Cytotoxin production by a marine Lyngbya strain (cyanobacterium) in a large-scale laboratory bioreactor. J. appl. Phycol. 3: 227-282.
2. Betina V (1994) Bioactive secondary metabolites of microorganisms, Progress in Industrial Microbiology, Vol 30, Elsevier, New York: 52-65.
3. Blokhin AV, Yoo H-D, Geralds RS, Nagle DG, Gerwick WH, Hamel E (1995) Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues. Molecular Pharm. 48: 523-531.
4. Craig GM, Schepartz SA, Suffness M, Grever MR (1993) The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. J. nat. Prod. 56: 1657-1668.
5. Fenical W (1982) Natural products chemistry in the marine environment. Science 215: 923-928.
6. Fenical W (1993) Chemical studies of marine bacteria: Developing a new resource. Chem. Rev. 93: 1673-1683.
7. Faulkner DJ (1995) Marine natural products. Nat. Prod. Rep. 11: 223-269.
8. Gerwick WH, Proteau PJ, Nagle DG, Hamel E, Blokhin A, Slate D (1994a) Structure of curacin A, a novel antimitotic, antiproliferative, and brine shrimp toxic natural product from the marine cyanobacterium Lyngbya majuscula. J. org. Chem. 59: 1243-45.
9. Gerwick WH, Roberts MA, Proteau PJ, Chen J-L (1994b) Screening cultured marine microalgae for anticancer-type activity. J. appl. Phycol. 6: 143-149.
10. Hamel E (1990) Interactions of tubulin with small ligands, in Microtubule Proteins (J Avila, ed.) CRC Press, Boca Raton, Florida, 89-191.
11. Hoemann MZ, Agrios KA, Aube J (1996) Total synthesis of curacin A. Tetrahedron Lett. 37: 953-956.
12. Ito H, Imai N, Takao K-i, Kobayashi S (1996) Enantioselective synthesis of curacin A. 2. Total synthesis of curacin A by condensation of C1-C7, C8-C17, and C18-C22 segments. Tetrahedron Lett. 37: 1799-1800.
13. Lai J-Y, Yu J, Mekonnen B, Falck JR (1996) Synthesis of curacin A, an antimitotic cyclopropane-thiazoline from the marine cyanobacterium Lyngbya majuscula. Tetrahedron Lett. 37: 7167-7170.
14. Moore RE, Patterson GML, Carmichael WW (1988) New pharmaceuticals from cultured blue-green algae, in Biomedical Importance of Marine Organisms, Memoirs of the California Academy of Sciences Number 13, (DG Fautin, ed.) California Academy of Sciences, San Francisco, California, 143-150.
15. Onoda T, Shirai R, Koiso Y, Iwasaki S (1996a) Asymmetric total synthesis of curacin A. Tetrahedron Lett. 37: 4397-4400.
16. Onoda T, Shirai R, Koiso Y, Iwasaki S (1996b) Synthetic study on curacin A: A novel antimitotic agent from the cyanobacterium Lyngbya majuscula. Tetrahedron 52: 14543-14562.
17. Staley JT (ed.) (1989) Bergey's Manual of Systematic Bacteriology, Vol 3, Williams and Wilkins, Baltimore, Maryland, 1719.
18. White JD, Kim T-S, Nambu M (1995) Synthesis of curacin A: a powerful antimitotic from the cyanobacterium Lyngbya majuscula. J. am. chem. Soc. 117: 5612-5613.
19. Wipf P, Wenjing X (1996) Total synthesis of the antimitotic marine natural product (+)-curacin A. J. org. Chem. 61: 6556-6562.
20. Yoo H-D, Gerwick WH (1995) Curacins B and C, new antimitotic natural products from the marine cyanobacterium Lyngbya majuscula. J. nat. Prod. 58: 1961-1965.